Fig. 1From: Artesunate shows potent anti-tumor activity in B-cell lymphomaPotent growth suppression by artesunate in B-cell lymphoma cell lines. The dose-response effect for each drug was tested within a clinically relevant concentration range, and cell growth was measured using CellTiterGlo following 72 h treatment. Relative luminescence units (RLU) compared to untreated cells is shown (mean ± SD, n = 2–4)Back to article page